| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale
|
Freedman, Barry I.
|
|
|
5 |
3 |
p. 278-288
|
article
|
| 2 |
A Systematic Review and Meta-Analysis of Depression and Protein–Energy Wasting in Kidney Disease
|
Gregg, L. Parker
|
|
|
5 |
3 |
p. 318-330
|
article
|
| 3 |
A Systematic Review of the Acute Effects of Hemodialysis on Skeletal Muscle Perfusion, Metabolism, and Function
|
Almushayt, Shatha J.
|
|
|
5 |
3 |
p. 307-317
|
article
|
| 4 |
Brazilian Network of Pediatric Nephrotic Syndrome (REBRASNI)
|
Feltran, Luciana S.
|
|
|
5 |
3 |
p. 358-362
|
article
|
| 5 |
Clinical Phenotypes and Long-term Prognosis in White Patients With Biopsy-Verified Hypertensive Nephrosclerosis
|
Øvrehus, Marius A.
|
|
|
5 |
3 |
p. 339-347
|
article
|
| 6 |
Corrigendum to “Boudard D, Aureli F, Laurent B, et al. Chronic oral exposure to synthetic amorphous silica (NM-200) results in renal and liver lesions in mice.” Kidney Int Rep. 2019;4:1463–1471
|
|
|
|
5 |
3 |
p. 382
|
article
|
| 7 |
Corrigendum to “Cataldo E, Cinquantini F, Priola AM, et al. Spontaneous renal artery dissection in Ehler–Danlos syndrome.” Kidney Int Rep. 2019;4:1649–1652
|
|
|
|
5 |
3 |
p. 382
|
article
|
| 8 |
Corrigendum to “Zand L, Canetta P, Lafayette R, et al. An open-label pilot study of adrenocorticotrophic hormone in the treatment of IgA nephropathy at high risk of progression.” Kidney Int Rep. 2020;5:58–65
|
|
|
|
5 |
3 |
p. 382
|
article
|
| 9 |
DNAJB9 Is Not Transcriptionally Upregulated in the Glomerulus in Fibrillary Glomerulonephritis
|
Avasare, Rupali S.
|
|
|
5 |
3 |
p. 368-372
|
article
|
| 10 |
Falsely Elevated Serum Creatinine Associated With IgM Paraproteinemia
|
Mase, Hiroyasu
|
|
|
5 |
3 |
p. 377-381
|
article
|
| 11 |
Identification of Two Forms of Human Plasma Renalase, and Their Association With All-Cause Mortality
|
Chang, J.
|
|
|
5 |
3 |
p. 362-368
|
article
|
| 12 |
Intensive Home Hemodialysis Survival Comparable to Deceased Donor Kidney Transplantation
|
Nishio-Lucar, Angie G.
|
|
|
5 |
3 |
p. 296-306
|
article
|
| 13 |
Kidney Health for Everyone Everywhere—From Prevention to Detection and Equitable Access to Care
|
Li, Philip Kam-Tao
|
|
|
5 |
3 |
p. 245-251
|
article
|
| 14 |
Launching APOLLO: The Role of APOL1 Genetic Variants in Live- and Deceased-Donor Kidney Transplantation
|
Fuentes, Federico
|
|
|
5 |
3 |
p. 252-254
|
article
|
| 15 |
Light Chain Crystal Podocytopathy in a Patient With Systemic Indolent B-Cell Lymphoma
|
Kamar, Fareed
|
|
|
5 |
3 |
p. 373-376
|
article
|
| 16 |
Preventing CKD in Developed Countries
|
Luyckx, Valerie A.
|
|
|
5 |
3 |
p. 263-277
|
article
|
| 17 |
Preventing CKD in Low- and Middle-Income Countries: A Call for Urgent Action
|
Ameh, Oluwatoyin I.
|
|
|
5 |
3 |
p. 255-262
|
article
|
| 18 |
Red Blood Cell AE1/Band 3 Transports in Dominant Distal Renal Tubular Acidosis Patients
|
Bertocchio, Jean-Philippe
|
|
|
5 |
3 |
p. 348-357
|
article
|
| 19 |
Rituximab in Patients With Phospholipase A2 Receptor–Associated Membranous Nephropathy and Severe CKD
|
Hanset, Nicolas
|
|
|
5 |
3 |
p. 331-338
|
article
|
| 20 |
The Marginal Cost of Frailty Among Medicare Patients on Hemodialysis
|
Sy, John
|
|
|
5 |
3 |
p. 289-295
|
article
|
Journal description